Tenth Annual Advances in Hematology and Oncology Fall Virtual Symposium

October 30, 2021

THIS SYMPOSIUM HAS BEEN CHANGED TO A VIRTUAL EVENT!

The practice of clinical hematology and oncology has been rapidly changing in recent years. Diseases and conditions that previously were extraordinarily difficult to manage have seen new treatment options emerge that have significantly improved clinical outcomes. The 10th Annual Advances in Hematology and Oncology Fall Symposium will update participants on symptom management, prostate cancer, transplantation and cellular therapies for multiple myeloma, immune therapy for lung cancer, fertility preservation and more.

The program is designed to provide practical information on evidence-based practice guidelines and the availability of cancer clinical trials. It is directed at clinicians involved in the treatment of oncology patients including physicians, physician assistants, pharmacists, nurse practitioners.

 

 

 

Target Audience

Physicians, Physician Assistants, Nurse Practitioners, Pharmacists, Registered Nurses

Learning Objectives

  1. Attendees will be able to identify current evidence-based practice guidelines for topics presented.
  2. Attendees will be able to identify current available clinical trials for potential enrollment to benefit their patients. 
  3. Discuss the most current scientific and clinical research data and apply information to clinical practice. 
Additional information

Contact

Name: 
Dan Bullock
Phone Number: 
+1 (414) 805-4617
Course summary
Available credit: 
  • 3.75 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 3.75 Hours of Participation
    Hours of Participation credit.
Course opens: 
09/22/2021
Course expires: 
12/31/2021
Event starts: 
10/30/2021 - 8:00am
Event ends: 
10/30/2021 - 12:00pm
Cost:
$0.00

AGENDA

7:00-7:55AM      Breakfast/Viewing Exhibits            

7:55-8:00AM      Introduction | John Burfeind, MD

8:00-8:45 AM     Selecting, Administering and Monitoring Immunotherapy for Lung Cancer | David Gerber, MD

8:45-9:30AM      Autologous Stem Cell Transplantation and Cellular Therapies for Multiple Myeloma | Meera Mohan, MD, MS

9:30-10:15AM    PSMA in Prostate Cancer | Kathryn Bylow, MD

10:15-10:30AM  Break/View Exhibits

10:30-11:15AM    Breakout Sessions:

  1. Implementing Scalp Cooling for Chemotherapy Induced Alopecia at a Community-Based Cancer Center | Linda Amacher, RN, BSN, OCN, Denise Herriges, RN, BSN, OCN, and Denise Portz, MSN, RN, ACNS-BC, AOCNS
  2. Management of Venuous Thromboembolism | Patrick Foy, MD

11:15-12:00PM  Fertility Preservation: The Future is Bright | Stephanie Gunderson, MD

12:00                  Adjournment/Lunch

 

 

 

Guest Speakers

David E. Gerber, MD
Professor of Internal Medicine and Population Data Sciences
Associate Director of Clinical Research
Harold C. Simmons Comprehensive Cancer Center
UT Southwestern Medical Center

Linda Amacher, RN, BSN, OCN
Infusion Staff RN
Division of Hematology & Oncology
Froedtert & the Medical College of Wisconsin 

Kathryn Bylow, MD
Associate Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin

Patrick C. Foy, MD
Associate Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin

Stephanie Gunderson, MD
Assistant Professor
Department of Obstetrics & Gynecology
Medical College of Wisconsin

Denise Herriges, RN, BSN, OCN
Infusion Staff RN
Division of Hematology and Oncology
Froedtert & the Medical College of Wisconsin

Meera Mohan, MD, MS
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin

Denise Portz, MSN, RN, ACNS-BC, AOCNS
Oncology Clinical Nurse Specialist
Division of Hematology and Oncology
Froedtert & the Medical College of Wisconsin

Planning Committee 

John Burfeind, MD, Program Co-Director
Amy Harker-Murray, MD, Program Co-Director
Dan Bullock

All persons in control of content have NO relevant relationships to disclose with the exception of:
 

NameCompanyRelationship 
David E. Gerber, MD

AstraZeneca, Karyopharm, BerGenBio

Gilead

Samsung Bioepis, Catalyst Pharmaceuticals, BMS Steering Committee, Bei Gene, Ltd., Mriati Therapeutics, Inc., Janssen Scientific

Research 

Investor

Consulting

   
   
 

 

 

In accordance with the ACCME® standards for Commercial Support # 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of resolution process and resolved.

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 3.75 hours of participation for continuing education for allied health professionals.

 

Available Credit

  • 3.75 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 3.75 Hours of Participation
    Hours of Participation credit.

Price

Cost:
$0.00
Please login or register to take this course.

This course is complementary however registration is required. To register for this course click the "Take Course" button.

A link to our event portal will be emailed to all attendees on the week of October 25th to access our program.